Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
The entire MassHealth budget for fiscal year 2026 is $18.2 billion
The questionnaire asks about: Your height, weight, and BMI calculations Weight management methods you've tried before Your current health conditions and medications Family medical history related to weight management Your weight loss goals and what you hope to achieve Licensed healthcare professionals will review your confidential responses to determine if semaglutide may be appropriate for you
L-Carnitine helps shift this balance by encouraging the body to prioritize fat as a fuel source while supporting muscle repair